Dr Reddy US arm acquires rights to Valeant's derma product
This article was originally published in Scrip
Executive Summary
Promius Pharma, the US arm of Dr Reddy's Laboratories, has acquired the rights to manufacture, distribute and market Valeant Pharmaceuticals' Cloderm (clocortolone pivalate 0.1%) cream in the US.